Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2015 Financial Results
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.16 +0.01 (0.32%)
Previous Close $3.15    52 Week High $30.41 
Open $3.15    52 Week Low $9.40 
Day High $3.16    P/E N/A 
Day Low $3.15    EPS $-21.87 
Volume 8,854,611